132 related articles for article (PubMed ID: 12702150)
21. CD44v10, osteopontin and lymphoma growth retardation by a CD44v10-specific antibody.
Megaptche AP; Erb U; Büchler MW; Zöller M
Immunol Cell Biol; 2014 Sep; 92(8):709-20. PubMed ID: 24935458
[TBL] [Abstract][Full Text] [Related]
22. Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons.
Bennett KL; Modrell B; Greenfield B; Bartolazzi A; Stamenkovic I; Peach R; Jackson DG; Spring F; Aruffo A
J Cell Biol; 1995 Dec; 131(6 Pt 1):1623-33. PubMed ID: 8522617
[TBL] [Abstract][Full Text] [Related]
23. The density and type of MECA-79-positive high endothelial venules correlate with lymphocytic infiltration and tumour regression in primary cutaneous melanoma.
Avram G; Sánchez-Sendra B; Martín JM; Terrádez L; Ramos D; Monteagudo C
Histopathology; 2013 Dec; 63(6):852-61. PubMed ID: 24102908
[TBL] [Abstract][Full Text] [Related]
24. Expression of CD44 splice variants in human skin and epidermal tumours.
Seiter S; Tilgen W; Herrmann K; Schadendorf D; Patzelt E; Möller P; Zöller M
Virchows Arch; 1996 Jun; 428(3):141-9. PubMed ID: 8688968
[TBL] [Abstract][Full Text] [Related]
25. Expression of CD44 and the pattern of CD44 alternative splicing in uveal melanoma.
Danen EH; ten Berge PJ; van Muijen GN; Jager MJ; Ruiter DJ
Melanoma Res; 1996 Feb; 6(1):31-5. PubMed ID: 8640067
[TBL] [Abstract][Full Text] [Related]
26. Brain metastasis is predetermined in early stages of cutaneous melanoma by CD44v6 expression through epigenetic regulation of the spliceosome.
Marzese DM; Liu M; Huynh JL; Hirose H; Donovan NC; Huynh KT; Kiyohara E; Chong K; Cheng D; Tanaka R; Wang J; Morton DL; Barkhoudarian G; Kelly DF; Hoon DS
Pigment Cell Melanoma Res; 2015 Jan; 28(1):82-93. PubMed ID: 25169209
[TBL] [Abstract][Full Text] [Related]
27. Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon.
Jackson DG; Bell JI; Dickinson R; Timans J; Shields J; Whittle N
J Cell Biol; 1995 Feb; 128(4):673-85. PubMed ID: 7532175
[TBL] [Abstract][Full Text] [Related]
28. The role of αβ T-cells in spontaneous regression of melanoma tumors in swine.
Cizkova J; Sinkorova Z; Strnadova K; Cervinkova M; Horak V; Sinkora J; Stepanova K; Sinkora M
Dev Comp Immunol; 2019 Mar; 92():60-68. PubMed ID: 30308209
[TBL] [Abstract][Full Text] [Related]
29. Tumor-infiltrating lymphocytes and their significance in melanoma prognosis.
Schatton T; Scolyer RA; Thompson JF; Mihm MC
Methods Mol Biol; 2014; 1102():287-324. PubMed ID: 24258985
[TBL] [Abstract][Full Text] [Related]
30. CD44/chondroitin sulfate proteoglycan and alpha 2 beta 1 integrin mediate human melanoma cell migration on type IV collagen and invasion of basement membranes.
Knutson JR; Iida J; Fields GB; McCarthy JB
Mol Biol Cell; 1996 Mar; 7(3):383-96. PubMed ID: 8868467
[TBL] [Abstract][Full Text] [Related]
31. Immunophenotypic characterization of tumor infiltrating lymphocytes and peripheral blood lymphocytes isolated from melanomatous and non-melanomatous Sinclair miniature swine.
Morgan CD; Measel JW; Amoss MS; Rao A; Greene JF
Vet Immunol Immunopathol; 1996 Dec; 55(1-3):189-203. PubMed ID: 9014317
[TBL] [Abstract][Full Text] [Related]
32. Expression of cell adhesion molecules in human melanoma cell lines and their role in cytotoxicity mediated by tumor-infiltrating lymphocytes.
Pandolfi F; Trentin L; Boyle LA; Stamenkovic I; Byers HR; Colvin RB; Kurnick JT
Cancer; 1992 Mar; 69(5):1165-73. PubMed ID: 1739916
[TBL] [Abstract][Full Text] [Related]
33. Absence of amplification of CD4+CD25(high) regulatory T cells during in vitro expansion of tumor-infiltrating lymphocytes in melanoma patients.
Knol AC; Lemaître F; Pandolfino MC; Volteau C; Quéreux G; Saiagh S; Khammari A; Viguier M; Dréno B
Exp Dermatol; 2008 May; 17(5):436-45. PubMed ID: 18312383
[TBL] [Abstract][Full Text] [Related]
34. Immunohistological analysis of anti-melanoma host responses.
Strohal R; Marberger K; Pehamberger H; Stingl G
Arch Dermatol Res; 1994; 287(1):28-35. PubMed ID: 7726633
[TBL] [Abstract][Full Text] [Related]
35. Reduced level of CD44 and hyaluronan associated with unfavorable prognosis in clinical stage I cutaneous melanoma.
Karjalainen JM; Tammi RH; Tammi MI; Eskelinen MJ; Agren UM; Parkkinen JJ; Alhava EM; Kosma VM
Am J Pathol; 2000 Sep; 157(3):957-65. PubMed ID: 10980134
[TBL] [Abstract][Full Text] [Related]
36. Differential expressions of CD44 variants in tumors affecting the central nervous system.
Resnick DK; Resnick NM; Welch WC; Cooper DL
Mol Diagn; 1999 Sep; 4(3):219-32. PubMed ID: 10553022
[TBL] [Abstract][Full Text] [Related]
37. Involvement of CD44 variant isoform v10 in progenitor cell adhesion and maturation.
Rösel M; Khaldoyanidi S; Zawadzki V; Zöller M
Exp Hematol; 1999 Apr; 27(4):698-711. PubMed ID: 10210328
[TBL] [Abstract][Full Text] [Related]
38. CD44 phosphorylation regulates melanoma cell and fibroblast migration on, but not attachment to, a hyaluronan substratum.
Peck D; Isacke CM
Curr Biol; 1996 Jul; 6(7):884-90. PubMed ID: 8805300
[TBL] [Abstract][Full Text] [Related]
39. Expression of CD44 variant isoforms in malignant melanoma.
Seiter S; Schadendorf D; Herrmann K; Schneider M; Rösel M; Arch R; Tilgen W; Zöller M
Clin Cancer Res; 1996 Mar; 2(3):447-56. PubMed ID: 9816190
[TBL] [Abstract][Full Text] [Related]
40. Tumor endothelium selectively supports binding of IL-2-propagated tumor-infiltrating lymphocytes.
Salmi M; Grenman R; Grenman S; Nordman E; Jalkanen S
J Immunol; 1995 Jun; 154(11):6002-12. PubMed ID: 7751643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
